# Dapsone

NDC: 69367-409
Generic name: Dapsone
Labeler / Manufacturer: Westminster Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250821

FDA application: ANDA086841

## Active ingredients

- DAPSONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69367-409"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69367-409
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d317576-5edd-4c27-a00d-68b5944c04a8